Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?

被引：5
|
作者：
Kim, Dong Yun [1 ,2 ]
Park, Jun Yong [2 ,3 ,4 ]
机构：
[1] Yonsei Univ, Grad Sch Med, Dept Pharmacol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
[4] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2019年 / 8卷 / 05期
关键词：
FIBROSIS STAGE; STEATOHEPATITIS; ELASTOGRAPHY; MORTALITY;
D O I：
10.21037/hbsn.2019.05.08
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：522 / 524
页数：3
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease: An overview
    Mulhall, BP
    Ong, JP
    Younossi, ZM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (11) : 1136 - 1143
  • [2] Treatment of non-alcoholic fatty liver disease with focus on emerging drugs
    Marchesini, Giulio
    Moscatiello, Simona
    Agostini, Federica
    Villanova, Nicola
    Festi, Davide
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (01) : 121 - 136
  • [3] Non-alcoholic fatty liver disease (NAFLD) in Asia-More efforts are needed
    Li, Jie
    Nguyen, Mindie H.
    LIVER INTERNATIONAL, 2020, 40 (12) : 3144 - 3144
  • [4] Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood?
    Teresa Arias-Loste, Maria
    Iruzubieta, Paula
    Crespo, Javier
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (03) : 270 - 273
  • [5] Emerging drugs for non-alcoholic fatty liver disease
    Federico, Alessandro
    Niosi, Marco
    Blanco, Camillo Del Vecchio
    Loguercio, Carmela
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 145 - 158
  • [6] An overview of ferroptosis in non-alcoholic fatty liver disease
    Wang, Shendong
    Liu, Zhaojun
    Geng, Jiafeng
    Li, Liangge
    Feng, Xiujing
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [7] Paediatric non-alcoholic fatty liver disease: an overview
    AlKhater, S. A.
    OBESITY REVIEWS, 2015, 16 (05) : 393 - 405
  • [8] Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
    Prikhodko, Veronika A.
    Bezborodkina, Natalia N.
    Okovityi, Sergey V.
    BIOMEDICINES, 2022, 10 (02)
  • [9] Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (10) : 527 - 535
  • [10] More on the thrombocytopenia of the non-alcoholic fatty liver disease
    Carlos Olivares-Gazca, Juan
    Karen Nunez-Cortes, Ana
    Alicia Mendez-Huerta, Mariana
    Cantero-Fortiz, Yahveth
    Gerardo Orea-Martinez, Juan
    Ruiz-Arguelles, Guillermo J.
    HEMATOLOGY, 2017, 22 (05) : 316 - 319
12345